MLICM
CTIC

Metropolitan Life Insurance Company (MetLife)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,454
Closed -$22.9K – 2560
2023
Q1 		$22.9K Sell
5,454
-197
-3% -$1.02K ﹤0.01% 1817
2022
Q4 		$34K Hold
5,651
– – ﹤0.01% 1713
2022
Q3 		$32.9K Hold
5,651
– – ﹤0.01% 1738
2022
Q2 		$33.7K Buy
+5,651
New +$28.9K ﹤0.01% 1744
2018
Q3 		– Sell
-19,401
Closed -$96.6K – 2683
2018
Q2 		$96.6K Buy
+19,401
New +$84.9K ﹤0.01% 2338
2016
Q1 		– Sell
-12,287
Closed -$151K – 2604
2015
Q4 		$151K Buy
12,287
+1,868
+18% +$24.9K ﹤0.01% 2431
2015
Q3 		$152K Buy
10,419
+3,919
+60% +$67.7K ﹤0.01% 2466
2015
Q2 		$127K Sell
6,500
-4,642
-42% -$89.6K ﹤0.01% 2574
2015
Q1 		$202K Buy
11,142
+61
+0.6% +$1.37K ﹤0.01% 2048
2014
Q4 		$262K Hold
11,081
– – ﹤0.01% 2217
2014
Q3 		$268K Buy
11,081
+6,058
+121% +$157K ﹤0.01% 2172
2014
Q2 		$141K Sell
5,023
-4,726
-48% -$142K ﹤0.01% 2657
2014
Q1 		$331K Sell
9,749
-288
-3% -$9.84K ﹤0.01% 2085
2013
Q4 		$193K Buy
10,037
+563
+6% +$10.2K ﹤0.01% 2497
2013
Q3 		$155K Buy
+9,474
New +$110K ﹤0.01% 2604

Other funds holding CTIC

UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CTIC Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 5,454 shares — an estimated $22.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CTIC in Q3 2013 and held it in 15 quarters. The position peaked at $331K in Q1 2014. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,454 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $22.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2013 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CTI BioPharma Corp. (DE) Common Stock position peaked at $331K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.